- •Preface
- •Contributors
- •Dedication
- •INFECTIOUS DISEASES
- •ACINETOBACTER
- •BACILLUS SPECIES INFECTIONS
- •ESCHERICHIA COLI
- •GONOCOCCAL OCULAR DISEASE
- •INFECTIOUS MONONUCLEOSIS
- •MICROSPORIDIAL INFECTION
- •MOLLUSCUM CONTAGIOSUM
- •MORAXELLA
- •PROPIONIBACTERIUM ACNES
- •PROTEUS
- •PSEUDOMONAS AERUGINOSA
- •STREPTOCOCCUS
- •VARICELLA AND HERPES ZOSTER
- •PARASITIC DISEASES
- •PEDICULOSIS AND PHTHIRIASIS
- •NUTRITIONAL DISORDERS
- •INFLAMMATORY BOWEL DISEASE
- •DISORDERS OF CARBOHYDRATE METABOLISM
- •MUCOPOLYSACCHARIDOSIS IH
- •MUCOPOLYSACCHARIDOSIS IH/S
- •MUCOPOLYSACCHARIDOSIS II
- •MUCOPOLYSACCHARIDOSIS III
- •MUCOPOLYSACCHARIDOSIS IV
- •MUCOPOLYSACCHARIDOSIS VI
- •MUCOPOLYSACCHARIDOSIS VII
- •DISORDERS OF LIPID METABOLISM
- •HEMATOLOGIC AND CARDIOVASCULAR DISORDERS
- •CAROTID CAVERNOUS FISTULA
- •DERMATOLOGIC DISORDERS
- •ERYTHEMA MULTIFORME MAJOR
- •CONNECTIVE TISSUE DISORDERS
- •PSEUDOXANTHOMA ELASTICUM
- •RELAPSING POLYCHONDRITIS
- •UVEITIS ASSOCIATED WITH JUVENILE IDIOPATHIC ARTHRITIS
- •WEGENER GRANULOMATOSIS
- •WEILL–MARCHESANI SYNDROME
- •SKELETAL DISORDERS
- •PHAKOMATOSES
- •NEUROFIBROMATOSIS TYPE 1
- •STURGE–WEBER SYNDROME
- •NEUROLOGIC DISORDERS
- •ACQUIRED INFLAMMATORY DEMYELINATING NEUROPATHIES
- •CREUTZFELDT–JAKOB DISEASE
- •NEOPLASMS
- •JUVENILE XANTHOGRANULOMA
- •LEIOMYOMA
- •ORBITAL RHABDOMYOSARCOMA
- •SEBACEOUS GLAND CARCINOMA
- •SQUAMOUS CELL CARCINOMA
- •MANAGEMENT OF SCLERAL RUPTURES 871.4 AND LACERATIONS 871.2
- •IRIS LACERATIONS 364.74, IRIS HOLES 364.74, AND IRIDODIALYSIS 369.76
- •ORBITAL IMPLANT EXTRUSION
- •SHAKEN BABY SYNDROME
- •PAPILLORENAL SYNDROME
- •ANTERIOR CHAMBER
- •CHOROID
- •ANGIOID STREAKS
- •CHOROIDAL DETACHMENT
- •SYMPATHETIC OPHTHALMIA
- •CONJUNCTIVA
- •ALLERGIC CONJUNCTIVITIS
- •BACTERIAL CONJUNCTIVITIS
- •LIGNEOUS CONJUNCTIVITIS
- •OPHTHALMIA NEONATORUM
- •CORNEA
- •BACTERIAL CORNEAL ULCERS
- •CORNEAL MUCOUS PLAQUES
- •CORNEAL NEOVASCULARIZATION
- •FUCHS’ CORNEAL DYSTROPHY
- •KERATOCONJUNCTIVITIS SICCA AND SJÖGREN’S SYNDROME
- •LATTICE CORNEAL DYSTROPHY
- •NEUROPARALYTIC KERATITIS
- •PELLUCID MARGINAL DEGENERATION
- •EXTRAOCULAR MUSCLES
- •ACCOMMODATIVE ESOTROPIA
- •CONVERGENCE INSUFFICIENCY
- •MONOFIXATION SYNDROME
- •NYSTAGMUS
- •EYELIDS
- •BLEPHAROCHALASIS
- •BLEPHAROCONJUNCTIVITIS
- •EPICANTHUS
- •FACIAL MOVEMENT DISORDERS
- •FLOPPY EYELID SYNDROME
- •MARCUS GUNN SYNDROME
- •SEBORRHEIC BLEPHARITIS
- •XANTHELASMA
- •GLOBE
- •BACTERIAL ENDOPHTHALMITIS
- •FUNGAL ENDOPHTHALMITIS
- •INTRAOCULAR PRESSURE
- •ANGLE RECESSION GLAUCOMA
- •GLAUCOMA ASSOCIATED WITH ELEVATED VENOUS PRESSURE
- •GLAUCOMATOCYCLITIC CRISIS
- •NORMAL-TENSION GLAUCOMA (LOW-TENSION GLAUCOMA)
- •IRIS AND CILIARY BODY
- •ACCOMMODATIVE SPASM
- •LACRIMAL SYSTEM
- •LACRIMAL HYPOSECRETION
- •DISLOCATION OF THE LENS
- •LENTICONUS AND LENTIGLOBUS
- •MICROSPHEROPHAKIA
- •MACULA
- •CYSTOID MACULAR EDEMA
- •EPIMACULAR PROLIFERATION
- •OPTIC NERVE
- •ISCHEMIC OPTIC NEUROPATHIES
- •TRAUMATIC OPTIC NEUROPATHY
- •ORBIT
- •EXTERNAL ORBITAL FRACTURES
- •INTERNAL ORBITAL FRACTURES
- •OPTIC FORAMEN FRACTURES
- •RETINA
- •ACQUIRED RETINOSCHISIS
- •ACUTE RETINAL NECROSIS
- •DIFFUSE UNILATERAL SUBACUTE NEURORETINITIS
- •RETINOPATHY OF PREMATURITY
- •SCLERA
- •SCLEROMALACIA PERFORANS
- •VITREOUS
- •VITREOUS WICK SYNDROME
- •Index
Punnonen E, Laatikainen L: Prognosis of perforating eye injuries with intraocular foreign bodies. Acta Ophthalmol (Copenh) 67:483–491, 1989.
Rubsamen PE, Cousins SW, Winward KE, et al: Diagnostic ultrasound and pars plana vitrectomy in penetrating ocular trauma. Ophthalmology 101:809–814, 1994.
Seal DV, Kirkness CM: Criteria for intravitreal antibiotics during surgical removal of intraocular foreign bodies. Eye 6(Pt 5):465–468, 1992.
Soheilian M, Abolhasani A, Ahmadieh H, et al: Management of magnetic intravitreal foreign bodies in 71 eyes. Ophthalmic Surg Lasers Imaging 35:372–378, 2004.
Wani VB, Al-Ajmi M, Thalib L, et al: Vitrectomy for posterior segment intraocular foreign bodies: visual results and prognostic factors. Retina 23:654–660, 2003.
Williams DF, Mieler WF, Abrams GW, et al: Results and prognostic factors in penetrating ocular injuries with retained intraocular foreign bodies. Ophthalmology 95:911–916, 1988.
not be noted until the hyphema clears. As with other iris injuries, an iridodialysis only infrequently results in visual symptoms such as monocular diplopia.
Differential diagnosis
All of the following entities present with iris atrophy or holes if iris trauma has not occurred:
●Iridocorneal endothelial (ICE) syndromes;
●Postinflammatory iris atrophy (e.g. herpes zoster);
●Ischemia (e.g. angle-closure glaucoma, anterior segment ischemia);
●Aging;
●Congenital defects (e.g. megalocornea, aniridia);
●Several ocular syndromes and systemic diseases (e.g. Axen- feld–Rieger syndrome).
158 IRIS LACERATIONS 364.74, IRIS HOLES 364.74, AND IRIDODIALYSIS 369.76
Richard A. Harper, MD
Little Rock, Arkansas
ETIOLOGY
Iris lacerations and holes are partial or full-thickness iris defects that are most often caused by trauma; the trauma can be surgical or nonsurgical.
An iridodialysis is a separation of the thin, weak iris root from its attachment to the ciliary body and scleral spur. This usually results in an irregular or D-shaped pupil. Iridodialysis is also most commonly caused by trauma to the globe, but may also be surgically induced.
COURSE/PROGNOSIS
An iris wound almost always results in a permanent defect because the healing abilities of the iris are minimal to absent unless the wound’s edges are apposed.
Prognosis is good for small or isolated iris injuries. Symptoms and ocular morbidity are determined by the size of the iris defect and the damage to other ocular structures.
DIAGNOSIS
Small iris holes may be difficult to detect unless the pigment epithelium has been involved, resulting in transillumination defects. Larger defects and those that affect the pupillary sphincter often create abnormalities in pupil size (traumatic mydriasis), shape, or function. A common finding with sphincter injury is that of a small triangular defect in the pupillary border, oriented with the apex toward the peripheral iris. Extraneous light entering through iris defects may result in visual symptoms such as glare or monocular diplopia. Hyphema frequently coexists with iridodialysis because of the shearing of the vessel at the iris root. In these cases, the iridodialysis may
TREATMENT
Ocular
●Topical cycloplegics and steroids for traumatic iritis.
●Rest and observation as supportive measures.
●Opaque contact lenses with clear pupillary zones for control of symptoms.
Surgical
●Not often required unless there is symptomatic glare or monocular diplopia.
●Normally deferred until intraocular inflammation has resolved; may be done in conjunction with traumatic cataract extraction or at the time of corneoscleral laceration repair.
●Lacerations without tissue loss may be directly closed with 10-0 polypropylene suture.
IRIDODIALYSIS
Symptomatic defects can be closed using a double-armed suture technique. A 10-0 polypropylene suture with straight needles is passed through the limbus, 180 degrees away from the iridodialysis. The needle continues across the anterior chamber, through the disinserted iris root, and out through the chamber angle and sclera. The other needle is then passed through the same entry site and through the iris root in a mattress fashion. The suture is then tied, drawing the iris back into place.
COMPLICATIONS
Associated ocular complications primarily reflect damage to other parts of the eye secondary to trauma:
●Corneal edema;
●Corneoscleral lacerations;
●Traumatic cataract, subluxed or dislocated lens;
●Hyphema;
●Angle-recession glaucoma;
●Cyclodialysis/ciliary body detachment with possible hypotony;
●Vitreous hemorrhage;
●Retinal tears, edema, or hemorrhage;
●Retinal detachment or dialysis;
●Choroidal rupture;
●Traumatic optic neuropathy.
Iridodialysis and158Holes,CHAPTERIris Lacerations, Iris •
291
Injuries Nonmechanical and Mechanical • 14 SECTION
COMMENTS
Iris injury due to blunt ocular trauma may result from one of two possible mechanisms. The first mechanism is that of direct corneal compression with resulting expansion of the globe in the coronal plane. This expansion directly stresses the area of the iris root and ciliary body. The second possible mechanism is that of a compression wave created in the aqueous as a result of blunt trauma. The subsequent posterior and lateral flow of the aqueous could cause sphincter or iris damage due to iris displacement.
Iris lacerations, holes, and iridodialyses by themselves do not commonly cause symptoms or ocular complications. Their primary significance lies in raising suspicions regarding injury to other ocular structures. Only if the iris defect creates significant symptoms should treatment be considered.
REFERENCES
Crouch ER, Williams PB: Trauma: ruptures and bleeding. In: Tasman W, Jaeger EA, eds: Duane’s clinical ophthalmology. Philadelphia, Lippin- cott-Raven, 1997:IV:1–3.
Hanna C, Roy FH: Iris wound healing. Arch Ophthalmol 88:296–304, 1972.
Hersh PS, Zagelbaum BM, et al: Blunt iris injury. In: Albert DM, Jakobiec FA, eds: Principles and practice of ophthalmology. Philadelphia, WB Saunders, 2000:5208–5209.
Steinert RF: Iris trauma. In: Shingleton BJ, Hersh PS, Kenyon KR, eds: Eye trauma. St Louis, CV Mosby, 1991:95–103.
Wachler BB, Drueger RR: Double-armed McCannel suture for repair of traumatic iridodialysis. Am J Ophthalmol 122:109–110, 1996.
Waubke TN, Mellin KB: Treatment of iris injuries. In: Blodi F, Mackensen G, Neubauer H, eds: Surgical ophthalmology. Berlin, Springer, 1992: II:516–518.
159 ORBITAL IMPLANT EXTRUSION
996.59
Mark R. Levine, MD, FACS
Beechwood, Ohio
Amarpreet Singh, MD
Cleveland, Ohio
The loss of an eye because of enucleation or evisceration is emotionally traumatic, and is exacerbated by extrusion of an orbital implant. In general, the implant size used in enucleations is 18 to 22 mm. This (along with the prosthesis) maximally replaces the 6 mL of volume lost, prevents enophthalmos, superior tarsal sulcus deformity, and avoids the need for an oversized prosthesis and the complications associated with it. The implant in evisceration is as large as can be fit into the scleral envelope, which can be augmented with expansion sclerotomies or posterior placement of the implant.
There are three categories of implants used:
●Integrated: hydroxyapatite or porous polyethylene (Medpore);
●Non-integrated: silicone or acrylic spheres (methylmethacrylate);
●Biological: dermis fat grafts.
Problems formerly created by the rough surfaces of hydroxyapatite (HA) and porous polyethylene (PP) implants have been
FIGURE 159.1. Extruding tantalum mesh from anophthalmic socket.
minimized by the recent refinement and smoothing of these surfaces as well as the use of wrapping materials. A secondary implant is always desirable to maintain orbital volume, minimize superior tarsal sulcus deformity, promote motility, and maximize cosmetic acceptability. It is important that the implant be centrally placed to facilitate the proper fit of a prosthesis.
ETIOLOGY
Extrusions may occur early in the postoperative period or many years after the initial implant (Figure 159.1). The causes of early extrusion are edema, hemorrhage, infection, too large an implant, and faulty surgical technique. Late extrusion is caused by erosion of the tissue covering the anterior surface of the implant. This erosion is a result of friction from a rough prosthesis or rough implant, such as hydroxyapatite, covered only by conjunctiva and Tenon’s capsule. The erosion leads to extrusion either because of a secondary infection or because of epithelialization of the socket, with resulting contraction of the orbital tissues.
COURSE/PROGNOSIS
In evisceration, if the conjunctiva and Tenon’s capsule have retracted but the scleral incision is intact, re-epithelialization may occur. If the sclera dehisces, exposing the implant, the likely course will be further wound dehiscence and extrusion. At this point, re-suturing the sclera is rarely effective.
In enucleation, retraction of the conjunctiva and Tenon’s capsule with implant exposure leads to a natural course of extension of the exposure, with or without infection. If a porous implant is wrapped in fascia and the fascia is exposed, re-epi- thelialization and vascularization may occur. This is more likely if the defect is only 2 to 3 mm and the prosthesis is removed or vaulted. Larger defects of 10 to 15 mm will only occasionally re-epithelialize and vascularize.
Infection is another complication of orbital implant surgery. The fascial wrap may become infected or may resorb, during which time significant mucus production will be noted. An infection is more likely to develop from the combination of a moist socket, low-grade bacteria (usually Staphylococcus
292
epidermidis), and the presence of a prosthesis. In the case of an infection, extrusion of the implant is usually inevitable.
DIAGNOSIS
The presence of a defect in the conjunctiva and Tenon’s capsule and visualization of the implant require immediate attention. Significant muco-purulent discharge should alert the clinician to the possibility of socket infection and implant exposure, be it large or small.
TREATMENT
Systemic
●Systemic antibiotics when the socket is infected.
Local
●Good lid hygiene, using moist swabs as often as necessary.
●Observation for enlarging defects (keeping in mind that defects up to 3 mm usually resolve with conservative management).
●Removal or vaulting of the prosthesis to remove pressure from the affected area.
●Obtaining of a culture and sensitivity of any low-grade infection and use of appropriate topical antibiotics.
Surgical
Complete extrusion in cases of enucleation (no infection present)
●Immediate replacement with a fascia-enveloped sphere.
●Conjunctiva and Tenon’s capsule are dissected from the rest of the orbital contents, taking care not to injure the recti muscles.
●A cavity may be present within the muscle cone if extrusion occurred within 2 to 3 weeks of placement of the implant. More commonly, the extraocular muscle and Tenon’s capsule will have retracted into a small fibrotic mass.
●Sharp dissection is used to create a cavity in this mass.
●Excision of scar tissue posteriorly, or a posterior dissection, is carried out until Tenon’s capsule and the muscles can stretch over the implant.
●A piece of autogenous fascia (either fascia lata, removed from the leg or temporalis fascia from the temple) is wrapped around an appropriately sized implant (16 to 20 mm), and sutured with 5-0 vicryl. Note that fascia as a wrap adds an additional 1 to 2 mm to the implant size.
●Sutures of 4-0 double-armed vicryl are placed in each of the four quadrants of the fascia-enveloped sphere.
●The implant is placed in the socket and the sutures are brought out from each socket quadrant between the recti muscles, through Tenon’s capsule and the conjunctiva, and fixed externally to position the implant.
●Tenon’s capsule posterior to the recti muscles is sutured over the fascial ball with interrupted 5-0 vicryl, taking bites of the fascia to create a barrier and centrally fix the implant.
●The recti muscles, if found, are gently approximated with 5-0 vicryl.
●Anterior Tenon’s capsule is closed with 6-0 vicryl and the conjunctiva is closed with locking 6-0 chromic catgut suture.
●A small conformer is inserted so as not to place tension on the suture line.
●Two 4-0 silk tarsorrhaphies are performed, and a pressure patch is applied for 3–4 days.
Notes
●The choice of implant can be either PP, HA, silicone or acrylic sphere. The implant should be wrapped for added support and provide an additional barrier to extrusion.
●In the case of a porous implant, it too should be wrapped with fascia; however, multiple window defects are placed in the fascia to enhance vascular ingrowth.
●If the socket is infected, it is filled with antibioticimpregnated gauze and replaced often until the infection is resolved (5 to 10 days); a secondary implant is placed at a later time.
Implant replacement in an evisceration
●The scleral pouch is irrigated with antibiotics.
●The implant of choice is placed in the scleral pouch so there is no tension on the scleral closure.
●If the scleral pouch is a too small, expansion sclerotomies are made with either radial or circumferential cuts. This is particularly important for vascular ingrowth if a HA or PP implant is being placed.
●The sclera is closed with running 5-0 vicryl, and Tenon’s capsule and the conjunctiva are closed with locking 6-0 chromic catgut.
●Tarsorrhaphy is performed, and pressure patches are applied. A conformer is not needed, as the cul-de-sacs are formed and there will be no pressure on the suture line.
NOTES
●In the case where the volume of the scleral pouch is inadequate even after expansion sclerotomies, a posterior placement of the implant can be performed. The posterior sclera is cut from 3 to 9 o’clock and the implant placed within the muscle cone behind the posterior sclera. The posterior sclera is closed with running 5-0 vicryl and the anterior sclera is sutured to the posterior sclera with running 5-0 vicryl. The conjunctiva and Tenon’s is closed with 6-0 chromic catgut. This permits a large enough sphere without placing tension on the sclera.
Large defects with implant exposure of 10 to 15 mm
●Immediate patch grafting with fascia.
●The conjunctiva and Tenon’s capsule are dissected off the implant for several additional millimeters.
●The defect is irrigated with antibiotic solution copiously.
●Burr down the implant to reduce the size and remove areas of superficial infection.
●A piece of autogenous fascia (either fascia lata, removed from the leg or temporalis fascia from the temple) is placed over the implant, extending into all four quadrants of the socket.
●5-0 vicryl sutures are placed into the fascia through Tenon’s capsule, exiting through the conjunctiva in all four quadrants and tied.
●The conjunctiva and Tenon’s capsule are closed over the fascia, taking bites of the fascia every third suture.
●If there are inadequate conjunctiva and Tenon’s capsule, a bipedicle conjunctival flap is brought down from the upper fornix to cover the defect, and the upper fornix is allowed to heal by secondary intention.
159ExtrusionCHAPTERImplant Orbital •
293
Injuries Nonmechanical and Mechanical • 14 SECTION
NOTES |
ries. The syndrome is commonly seen in infants under the age |
● A fornix based tarsoconjunctival flap from the upper eyelid |
of two but can also be found in children up to five years of age. |
also provides an excellent alternative approach in cases |
The underlying injuries are often hidden by the perpetrators |
where recurrent exposure is an issue. |
and external findings of body or head trauma may be difficult |
|
to detect initially. |
COMPLICATIONS
●Re-extrusion may occur, requiring either a dermis fat-graft repair, a delay of 6 months to a year prior to placing another secondary implant.
●A possibly infected porous implant must be removed and replaced with a new implant, either immediately or later.
COMMENTS
A dermis fat graft can always be substituted in implant extrusion. It must be of adequate size (25 mm × 25 mm) and must be placed in a non-infected orbit; otherwise it will become infected and will be absorbed. The complications of dermis fat grafts include atrophy and cyst or hair formation.
Autogenous fascia (as opposed to banked sclera) remains the safest and most convenient wrapping material. It is cost-effec- tive and does not carry the risk of disease transmission. Topical antibiotic drops without steroid should be used to promote rapid wound healing.
REFERENCES
Levine MR, Older JJ: Enucleation surgery and treatment of the extruding orbital implant. In: Stewart WB, ed: Ophthalmic plastic surgery. A manual prepared for the use of graduates in medicine. 4th edn. San Francisco, American Academy of Ophthalmology, 1983:43–47.
Long JA, et al: Evisceration: a new technique of trans-scleral implant placement. Ophthal Plast Reconstr Surg 16(5):322–325, 2000.
Oberfeld S, Levine MR: Diagnosis and treatment of complications of enucleation and orbital implant surgery. Advan Ophthal Plast Reconstr Surg 8:107–117, 1990.
Soparkar CN, Patrinely JR: Tarsal patch-flap for obital implant exposure. Ophthal Plast Reconstr Surg 14(6):391–397, 1998.
160 SHAKEN BABY SYNDROME
995.55
William Barry Lee, MD
Atlanta, Georgia
Henry S. O’Halloran, MD, DOphth, FRCSI
San Diego, California
ETIOLOGY/INCIDENCE
Shaken baby syndrome, also known as whiplash shaken infant syndrome or shaken-impact syndrome, is a form of child abuse with an estimated annual incidence of 4000 cases per year. In the United States, one million children are severely abused annually. This syndrome includes nonaccidental head and body trauma with resulting intracranial hemorrhages, occult bone fractures, and retinal hemorrhages. The sustained injuries can result from violent shaking, direct impact, or compression inju-
COURSE/PROGNOSIS
A high rate of mortality and morbidity is associated with shaken baby syndrome with mortality rates ranging from 15% to 40%. One third of identified patients with this syndrome die acutely with a significant proportion of survivors suffering severe neurological injury. Mortality was associated with extensive retinal injury, nonreactive pupils, and midline shifting of the brain. An additional one fifth of survivors have permanent visual impairment with cerebral injury accounting for the most common cause for profound vision loss. In addition, several studies have shown a correlation between the severity of retinal hemorrhage and the severity of head injury. The vast majority of intraocular injuries should be managed with observation in the acute phases with stabilization of life-threatening injuries including adequate ventilation and oxygenation by the primary care provider.
Shaken baby syndrome involves non-accidental injury exerted on a child by violent shaking and results in repetitive angular acceleration-deceleration motion similar to the force at the end of a whip. This motion creates high gravitational forces directed to the child’s head. Brain injury can occur from compression or distention of the infant brain with direct axonal injury, direct trauma creating stress and tearing of blood vessels, and indirect damage from swelling, ischemia, hypoxia, and altered vasculature. Eye injuries are postulated to occur from either venous obstruction in the retina as a result of increased intracranial pressure or traction of the vitreous on the retina creating splitting or folds within the retinal layers.
DIAGNOSIS
Shaken baby presentations can vary dramatically from very mild and nonspecific complaints to severe and immediate lifethreatening identifiable head injuries. The infants often present with lethargy, poor feeding, irritability, and/or vomiting and are often suspected of having an infection or intestinal/feeding disorders upon initial screening examinations because of lack of external findings of head or bodily injuries.
In the most severe situations, the infant can become immediately unconscious and exhibit impending central nervous system dysfunction including convulsions, comas, or respiratory failure.
A careful, yet expedient physical examination can display additional injuries such as bruises, rib or long-bone fractures, abdominal trauma and head trauma. Repeated physical examinations should be performed to find additional injuries that may have been missed on initial testing. Head trauma can range from skull fractures, subdural and subarachnoid hemorrhages to spinal cord trauma and brainstem injury. Physical examination must include a comprehensive ophthalmologic examination as up to 95% of cases of shaken baby syndrome have ocular findings. A dilated fundus examination must be included because retinal hemorrhages have been documented to occur in up to 50%–100% of nonaccidental head trauma cases. While retinal hemorrhages are not pathognomonic for
294
FIGURE 160.1. Shaken baby syndrome.
shaken baby syndrome, they are highly suggestive of a shaking or impact injury and several studies have shown that they are usually absent in pediatric accidental head trauma. Retinal hemorrhages often occur in all layers of the retina with no identifiable predominant location. Additional ocular findings include other forms of posterior segment injury such as vitreous hemorrhage, retinal detachment, retinoschisis, choroidal rupture, retinal folds, and optic nerve injury (Figure 160.1).
Laboratory findings
Diagnostic testing depends on the stability of the patient and may be limited for critically ill infants requiring life support. Neuroimaging should be performed in all cases of shaken baby syndrome to quantify the degree of head trauma. Computed tomography (CT) of the head should be the initial image of choice, preferably with intravenous contrast and bone and softtissue windows. CT is ideal for detection of subdural/subarachnoid hemorrhages and mass effect. Magnetic resonance imaging (MRI) of the head should be used as an adjunct to CT if patient stability is present and can be performed several days after initial testing. MRI can greater define intraparenchymal brain lesions and has a greater rate of detection for subdural hematomas. A skeletal survey should be performed once patient stability is achieved to evaluate for fractures of the hands, feet, long bones, skull, spine, and ribs. A repeat skeletal survey 2 weeks after the initial evaluation can demonstrate healing fractures that may have been missed on initial films.
Differential diagnosis
Retinal hemorrhages are an important clinical finding in diagnosis of shaken baby syndrome, but they are not pathognomonic for the syndrome. The most likely causes of retinal hemorrhages in an infant or young child include birth trauma, hematological disorders, Terson syndrome, severe accidental head trauma, infection, cardiopulmonary resuscitation, and child abuse. An estimated 15%–30% of infants have retinal hemorrhages from birth trauma, but they are often associated with a traumatic birth and resolve by 4 weeks of age. Hematologic testing can rule out coagulopathies such as hemophilia, von Willebrand disease, and vitamin K deficiency, and laboratory testing can help with confirmation of an infection. Several reports have shown that retinal hemorrhages are rare findings in accidental head trauma.
COMMENT
The wide variety of injuries that may occur in the syndrome require a multidisciplinary team approach in management and should include a pediatrician, neurologist, radiologist, ophthalmologist and/or a pediatric neurosurgeon. A child abuse specialist, social worker, law enforcement officer and child protection services must also work closely with the medical team. Appropriate documentation of injuries is imperative for future legal investigations with careful and detailed documentation of history, presentation, and examination as a high proportion of these cases develop into legal investigations.
Shaken baby syndrome is a leading cause of morbidity and mortality in infants and young children. All infants suspected of child abuse and shaken baby syndrome must have a careful evaluation with a complete physical exam including a dilated fundus examination. A multidisciplinary healthcare team is imperative in diagnosis and management of victims suffering from shaken baby syndrome. With an increasing incidence and high probability of underdiagnosed or unreported cases, a thorough physical and ophthalmologic examination can be critical in diagnosis of shaken baby syndrome. A greater understanding of this syndrome is important for the education of not only health care providers, but also the public, as prevention is the only method for alleviation of this abusive syndrome.
REFERENCES
Caffey J: The whiplash shaken infant syndrome: manual shaking by the extremities with whiplash-induced intracranial and intraocular bleedings, linked with residual permanent brain damage and mental retardation. Pediatrics 54:396–403, 1974.
Kivlin JD, Simons KB, Lazoritz S, Ruttum MS: Shaken baby syndrome. Ophthalmology 107:1246–1254, 2000.
Levin AV: Ophthalmology of shaken baby syndrome. Neurosurg Clin N Am 13:201–211, 2002.
Pierre-Kahn V, Roche O, Dureau P, et al: Ophthalmologic findings in suspected child abuse victims with subdural hematomas. Ophthalmology 110:1718–1723, 2003.
Tsao K, Kazlas M, Weiter JJ: Ocular injuries in shaken baby. Int Ophthalmol Clin 42:145–155, 2002.
161 THERMAL BURNS 940.9
F. Hampton Roy, MD, FACS
Little Rock, Arkansas
The thermally burned patient may present a challenging management problem for the ophthalmologist. Although many seriously burned individuals with total-body burns may initially escape direct damage to the globe of the eye, complications resulting from the overall injury can have a devastating effect on the ocular system.
ETIOLOGY
Many severely burned patients may escape direct injury to the cornea and conjunctiva because of Bell’s phenomenon and the protection of the eyelids. On the other hand, many do suffer direct corneal and conjunctival injuries that are thermal in nature, caused by the flame itself or by hot gases. Some corneal
161 CHAPTERBurns Thermal •
295
Injuries Nonmechanical and Mechanical • 14 SECTION
injuries may also be toxic, caused by the combustion of toxic chemicals that are released when synthetic materials burn. Finally, severe corneal and ocular injuries may occur if hot liquids or molten metal explodes into the eyes. These more severe, direct ocular injuries behave much like toxic alkaline burns, with resultant avascular necrosis in some cases and symblepharon formation as well. They are managed much like toxic chemical injuries.
COURSE/PROGNOSIS
The course and the prognosis depend on the degree and extent of the burns, as well as on the status of the respiratory system. The ophthalmologist must assume that the patient will survive the injury, no matter how severe it appears.
DIAGNOSIS
The extent and degree of facial and eyelid burns should be established, although it may be difficult to determine the degree of the burns initially. The conjunctival and corneal injuries are then assessed. When the eyelids are swollen shut, the globes may be examined, after instillation of topical anesthetic, by opening the eyelids with Desmarres lid retractors. The extent of corneal and conjunctival burns is assessed with fluorescein. Foreign bodies, corneal lacerations, ruptured globe, and possible intraocular foreign bodies may be found, especially after injuries caused by explosion. The eyelids should be assessed for possible ectropion and entropion. It is imperative to analyze the extent of the ocular injury itself, and the extent and the degree of the total body burn must also be taken into account.
●Perform suture tarsorrhaphy if bandage contact lens fails to help re-epithelialize the cornea.
●The definitive treatment for third-degree eyelid burns is skin grafting; skin grafting will prevent cicatricial contractures of the eyelids and cicatricial ectropion, which in turn prevent exposure keratitis and potentially serious secondary corneal infection and ulceration. If eyelid contractures have already occurred, make relaxing incisions to release the contractures and then apply the skin grafts. Use split-thick- ness skin grafts or cultured skin on patients with large third-degree total-body burns.
●When the total-body burn is more than 50% to 60% and mostly third degree, there may not be enough normal skin to allow for early eyelid skin grafting, as the burned area must be replaced with skin from an unburned area. In such cases, a large, almost total tarsorrhaphy should be performed early to allow for healing time before the onset of contractures. If contractures occur before the tarsorrhaphy has healed, traction from the contractures may split the tarsorrhaphy open and cause it to fail. Leave a 5-mm opening medially for examination and to allow cross-fixation for children who may be in the amblyopic age group. If contractures have already developed before the tarsorrhaphy, sufficient relaxing incisions in the contracted tissue will allow the eyelid margins to come together without traction so that tarsorrhaphy may be performed successfully. Split-thick- ness skin grafts or cultured skin can be put into the tarsal bed thus created. If not enough skin is available from the patient to perform this lid grafting, time may be bought to allow the tarsorrhaphy to heal by placing donor skin, pigskin, or cultured skin onto the newly created subcutaneous bed. Later, during the reconstructive phase of therapy, the tarsorrhaphies may be released as the eyelids are rebuilt.
TREATMENT
Systemic
●Give intravenous antibiotics to avoid endogenous bacterial endophthalmitis.
●Give intravenous antifungal agents to prevent endogenous fungal endophthalmitis.
●Maintain fluid balance.
●Maintain nutritional status.
Ocular
●Remove foreign bodies.
●Debride necrotic tissue.
●Promote re-epithelialization of the cornea and conjunctiva and maintain intact epithelium throughout the course of the recuperation.
Supportive
●Maintain airway.
●Manage shock.
●Replace fluids.
●Prevent infection.
PRECAUTIONS
Scar tissue that may result from a burned cornea will not be prevented by corticosteroids. Furthermore, corticosteroids may delay the re-epithelialization and increase the chance of secondary infection.
COMPLICATIONS
●Pressure-patch corneal and conjunctival injuries with anti-
biotic ointment daily until re-epithelialization is complete. It must be emphasized that although the corneas may not be
●Use bandage contact lenses when facial, brow, or eyelid burns preclude pressure patching.
●Use bandage contact lenses also to protect an uninjured cornea and to promote re-epithelization of a burned cornea when entropion is present.
●Use sterile wet compresses and topical antibiotic ointment for firstand second-degree burns of the eyelids.
Surgical
●Repair corneal lacerations and ruptured globe, if present.
●Remove intraocular foreign body, if present.
injured initially, serious third-degree burns of the face and eyelids in the presence of a large third-degree total-body burn can lead to severe cicatricial contractures and ectropion of the eyelids. Exposure keratitis can ensue if tarsorrhaphy is not performed. Organisms of the Pseudomonas genus or other bacteria as well as fungi on the burned areas may find their way to the exposed cornea and cause serious corneal infection. This infection may be prevented by the use of aggressive early tarsorrhaphies. Prophylactic antibiotics do not always prevent corneal infections in such cases. This is especially true when the patient is upsidedown on a rotating bed and minimal therapy can be
296
given to the eyes. A tarsorrhaphy protects the corneas during this phase of the therapy in a severely burned patient.
COMMENTS
For severe conjunctival burns caused by exploding liquids or molten metal, severe necrosis of the conjunctiva and cornea may occur. These injuries behave like severe acid or alkali burns. Local mucosal grafts may be applied in such cases, and the use of symblepharon rings may also help to prevent symblepharon. Because these injuries are similar to severe chemical burns, the articles on acid and alkali burns provide further information on the management of these cases.
In large, total-body burns, the acute phase of the injuries requires frequent operations for debridement as well as skin grafting. Until these patients are totally covered with skin, they are susceptible to infections both systemically and locally. These patients need frequent follow-up care after the application of large tarsorrhaphies. Once tarsorrhaphies are healed, examinations may be less frequent, provided that the blood cultures remain negative and signs of orbital cellulitis do not occur.
When the entire burned area is covered, the reconstructive phase of therapy can begin. When reconstruction of the eyelids with skin grafting is successful, tarsorrhaphies may be released.
Significant corneal complications such as corneal ulcers caused by Pseudomonas species may be prevented by tarsorrhaphies; this technique is preferable to treating such an infection, especially in combination with lid retraction and exposure keratitis. For this reason, the need for adequate and early tarsorrhaphies to protect the corneas in the severely burned patient cannot be overemphasized.
REFERENCES
Bloom SM, Gittinger JW, Jr, Kazarian EL: Management of corneal contact thermal burns. Am J Ophthalmol 102:536, 1986.
Children’s Hospital Boston: Fire safety and burns. Online. Available at: Injury Statistics and Incidence Rates Children’s Hospital Boston Web site. Accessed April 22, 2005.
Deutsch TA, Feller DB: Paton and Goldberg’s management of ocular injuries. 2nd edn. Philadelphia, WB Saunders, 1985:99–103.
Guy RJ, Baldwin J, Kwedar S, Law EJ: Three-years’ experience in a regional burn center with burns of the eyes and eyelids. Ophthalmic Surg 13:383–386, 1982.
Kulwin DR, Kersten RC: Management of eyelid burns. In: Focal points: clinical modules for ophthalmologists. San Francisco, American Academy of Ophthalmology, 1990:8:module 2:1–10.
Wibbenmeyer LA, Amelon MJ, Torner JC, et al: Population-based assessment of burn injury in southern Iowa: identification of children and young-adult at-risk groups and behaviors. J Burn Care Rehabil 24(4): 2003.
161 CHAPTERBurns Thermal •
297
S E C T I O N
15 Unclassified Diseases or Conditions
162 HYPERTENSION 365.04
Jeffrey R. Parnell, MD
Chicago, Illinois
Lee M. Jampol, MD
Chicago, Illinois
Systemic hypertension can be associated with vascular constriction, leakage, and arteriosclerosis, which can affect the function of many target organs throughout the body. The eye is the only target organ in which arteries and veins can be directly viewed in vivo with ease and by noninvasive techniques. Changes in the vasculature observed in the retina in hypertensive patients may reflect the status of the vascular system throughout the body.
The eye has a complex vascular system in which blood supplies to the optic nerve, choroid, and retina are derived from distinct sources, each having special anatomic and physiologic properties. Each vascular system has a unique response to systemic hypertension, and it is useful to separate into categories the different manifestations in the eye. Hypertensive eye disease can take the form of hypertensive retinopathy, hypertensive choroidopathy, hypertensive optic neuropathy, or all three.
ETIOLOGY/INCIDENCE
Systemic hypertension accounts for more visits to physicians than any other disease. As many as 58 million adults in the United States are estimated to have the disease. It is estimated up to 25% of adults and 60% of patients over 60 may be hypertensive. Blacks and males are more often affected.
Over 90% of cases of hypertension are due to essential hypertension for which there is no known cause. Heredity and environmental factors such as a high sodium diet and sedentary life style may play a role.
The remaining 10% of cases can be divided into the secondary causes of systolic and diastolic hypertension or isolated systolic hypertension.
One percent of patients may develop malignant hypertension, a particularly severe and often sudden onset of elevated blood pressure.
●Secondary causes of systolic and diastolic hypertension:
●Renal vascular or parenchymal disease;
●Endocrine disease;
●Coarctation of the aorta;
●Eclampsia or pre-eclampsia;
●Neurologic disorders;
●Increased intravascular volume;
●Isolated causes of systolic hypertension:
●Increased cardiac output due to aortic valve insufficiency, arteriovenous fistula, patent ductus;
●Arteriosus, thyrotoxicosis, beri-beri, hyperkinetic circulation;
●Aortic rigidity.
COURSE/PROGNOSIS
In hypertensive retinopathy, acute elevations of blood pressure lead to retinal arterial vasoconstriction, an auto regulatory response. Persistent hypertension causes irreversible arteriolar narrowing. Chronically elevated pressure also causes sclerotic changes in the media of the arterial wall. Light-reflex changes observed on examination reflect the degree of sclerosis, which, in severe cases, may take on the appearance of burnished copper wire. Arteriolar occlusion may look like silver wire. At arteriovenous crossing sites, where the artery and vein share a common adventitial sheath, compression of the venule causes visible ‘nicking’ (Gunn’s sign) of variable severity. Salus’ sign refers to the abnormal deflection of the venule as it crosses the arteriole at an increasingly obtuse angle or even a right angle. Chronic hypertension may also cause occasional retinal microaneurysms. Arterial macroaneurysms are also seen in association with chronic hypertensive retinopathy. Sclerotic hypertensive vascular changes may contribute to branch or central vein occlusion and branch or central retinal artery occlusions.
Acute, malignant, or accelerated hypertension leads to leakage of the retinal arterioles, with decompensation of the inner blood-retina barrier. This may be manifested as extravasation of blood and lipoprotein into the retina in the form of superficial hemorrhages, cotton wool spots (infarcts), hard exudates (lipid), and capillary occlusions. Malignant hypertension also can cause hypertensive choroidopathy and hypertensive optic nerve changes. In hypertensive choroidopathy, fibrinoid changes in the choriocapillaris result in focal nonperfusion that leads to ischemia of the outer retina and the retinal pigment epithelium. Acute Elschnig’s spots are white or yellow patches of ischemic retinal pigment epithelium overlying occluded choriocapillaris. Acute exudation through the injured retinal pigment epithelium layer can lead to neurosensory detachments. These spots ‘heal’ and become hyperpigmented over time. Linear hyperpigmentation overlying choroidal arteries is called Seigrist’s streaks and represents hyperplastic retinal pigment epithelium. Elschnig’s spots, after healing, are also hyperpigmented.
299
Conditions or Diseases Unclassified • 15 SECTION
Disk edema is seen with severe hypertension. This swelling |
● |
Cotton-wool spots, lipid exudates, hemorrhages. |
of the nerve head may be secondary to hypertensive encepha- |
● |
Macular edema and exudate (macular star). |
lopathy with raised intracranial pressure, local ischemia, or |
● |
Disk edema, optic atrophy, anterior ischemic optic |
vascular (venous) congestion within the nerve. Anterior |
|
neuropathy. |
ischemic optic neuropathy and optic nerve atrophy can be |
● |
Focal or widespread neurosensory detachment. |
seen. |
|
|
DIAGNOSIS
Systemic hypertension is diagnosed when the diastolic blood pressure is 90 mm Hg or above or the systolic pressure is 140 mm Hg or above on two or more separate examinations. A new category termed pre-hypertension has been created which encompasses patients with systolic readings between 120– 139 mm Hg and diastolic pressures of 80–89. There has been a recent trend toward early diagnosis and treatment since ‘high normal’ readings may result in increased cardiovascular events. Malignant hypertension is diagnosed when systolic readings are above 200 mm Hg and/or the diastolic pressure is above 140 mm Hg.
The diagnosis of ocular changes associated with hypertension is largely a clinical one. Fluorescein angiography can be useful in some circumstances for delineating problems in the retinal and choroidal vasculature. Ocular coherence tomography may be useful in evaluating retinal edema and subretinal fluid. The scanning laser ophthalmoscope may be useful as a research tool in assessing vascular caliber and flow velocity.
The predictive value of diagnosing systemic hypertension based solely on retinal findings is only roughly 50%. People with poor blood pressure control are more likely to show retinal findings.
TREATMENT
●Early detection and treatment of systemic hypertension has led to dramatic reduction in the occurrence of severe hypertensive ocular disease.
●Diagnosis of hypertensive retinal vascular changes could provide guidance for systemic treatment and stratification of risk for development of clinical stroke, coronary artery disease and death.
●Co-management and early referral to an internist for prompt workup and institution of systemic antihypertensive therapy is essential. Blood pressure should be measured in all patients with retinal vascular occlusions.
●Aggressive treatment and hospitalization are required for malignant hypertension.
●Diuretics, β-blockers, vasodilators, angiotensin-converting enzyme inhibitors, and calcium channel blockers, alone or in combination therapy, are among the options for regulating blood pressure.
●Nonpharmacologic therapy may include a regimen of regular aerobic exercise, weight reduction, sodium restriction, potassium supplementation, and moderation of alcohol consumption.
COMPLICATIONS
●Central or branch retinal artery occlusion.
●Central or branch retinal vein occlusion.
●Macroaneurysm.
CLASSIFICATION SYSTEMS
Recent international management guidelines have implied an association between retinopathy grade with cardiovascular and cerebrovascular disease. Unfortunately, there is no universal or widely accepted classification system. The Keith, Wagner and Barker classification system is the oldest and most referenced system, but is not standardized.
A more clinically relevant classification system today may be the system developed by Tso and Jampol, which grades the retinal vasculature with reference photographs of the fundus.
1.Arterial narrowing:
a.Mild;
b.Moderate;
c.Severe.
2.Arteriovenous nicking:
a.Mild;
b.Moderate;
c.Branch venous occlusion.
3.Arteriosclerosis:
a.Mild;
b.Copper-wire appearance;
c.Silver-wire appearance.
4.Arterial tortuosity:
a.Mild;
b.Moderate;
c.Severe.
5.Branching angle of arteries:
a.Mild = 45 to 60 degrees;
b.Moderate = 60 to 90 degrees;
c.Severe = >90 degrees.
COMMENTS
Ocular findings in systemic hypertension depend on the degree of arteriosclerosis already present from independent causes such as aging, trauma, inflammation, or other vascular diseases. It has been suggested that aged or arteriosclerotic arterioles are less affected by acute elevation of blood pressure than are normal blood vessels and may actually provide a ‘protective’ effect. Diabetic patients, on the other hand, may experience accelerated diabetic retinopathy in the presence of elevated blood pressure.
REFERENCES
Brown SM, Jampol LM: New concepts of regulation of retinal vessel tone. Arch Ophthalmol 114:199–204, 1996.
Chobonian AV, et al: Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertention 42:1206–1252, 2003.
Guidelines Committee: 2003 European Society of Hypertension/European Society of Cardiology guidelines for management of arterial hypertension. J Hypertens 21:1011–1053, 2003.
Klein R, et al: Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 112:92–98, 1994.
300
